Table 1.
Characteristics of the SLE patients, n = 243
| Mean (range) or % | |
|---|---|
| Age (years) | 49 (18–88) |
| Females | 86·8% |
| Caucasian ethnicity | 90·1% |
| Disease duration (years) | 10·3 (0–45) |
| Prednisolone dosage (mg/day) | 5 (0–60) |
| SLICC/ACR damage index (score) | 1·1 (0–9) |
| SLEDAI‐2K (score) | 2·8 (0–24) |
| PGA (score) | 0·5 (0–4) |
| Patients meeting SLICC‐12 (%) | 239 (98·4) |
| Fulfilled ACR‐82 criteria (n) | 4.7 (3–9) |
| ACR‐82 criteria | n (%) |
|---|---|
| 1. Malar rash | 106 (43·6) |
| 2. Discoid rash | 39 (16·0) |
| 3. Photosensitivity | 124 (51·0) |
| 4. Oral ulcers | 28 (11·5) |
| 5. Arthritis | 184 (75·7) |
| 6. Serositis | 92 (37·9) |
| 7. Renal disorder | 62 (25·5) |
| 8. Neurological disorder | 13 (5·3) |
| 9. Haematological disorder | 139 (57·2) |
| 10. Immunological disorder | 122 (50·2) |
| 11. IF‐ANA | 240 (98·8) |
SLEDAI‐2K = systemic lupus erythematosus disease activity index 2000; SLICC = Systemic Lupus International Collaborating Clinics; ACR = American College of Rheumatology; PGA = physician's global assessment; IF‐ANA = immunofluorescence microscopy anti‐nuclear antibodies.